HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chen Chen Selected Research

MafK Transcription Factor

4/2017The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chen Chen Research Topics

Disease

419Neoplasms (Cancer)
11/2022 - 05/2002
120Inflammation (Inflammations)
10/2022 - 03/2007
86Neoplasm Metastasis (Metastasis)
11/2022 - 07/2007
83Infections
06/2022 - 04/2009
49Breast Neoplasms (Breast Cancer)
11/2022 - 01/2010
43Hypertension (High Blood Pressure)
07/2022 - 08/2011
38Fibrosis (Cirrhosis)
11/2022 - 12/2004
38Alzheimer Disease (Alzheimer's Disease)
04/2022 - 11/2006
38Insulin Resistance
01/2022 - 01/2006
36Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2011
35Stroke (Strokes)
07/2022 - 08/2011
35Lung Neoplasms (Lung Cancer)
02/2022 - 07/2009
34Heart Failure
09/2022 - 03/2004
33Carcinoma (Carcinomatosis)
01/2022 - 05/2002
31Cognitive Dysfunction
08/2022 - 01/2014
31Hypoxia (Hypoxemia)
06/2022 - 01/2012
31Carcinogenesis
05/2022 - 02/2011
31Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2015
29Obesity
07/2022 - 06/2003
28Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 01/2006
28COVID-19
12/2022 - 01/2020
28Nasopharyngeal Carcinoma
01/2022 - 07/2011
27Glioma (Gliomas)
01/2022 - 02/2012
24Wounds and Injuries (Trauma)
06/2022 - 03/2007
24Body Weight (Weight, Body)
05/2022 - 06/2003
24Hepatocellular Carcinoma (Hepatoma)
02/2022 - 01/2012
23Ischemia
01/2022 - 03/2005
22Ischemic Stroke
07/2022 - 11/2013
21Type 2 Diabetes Mellitus (MODY)
05/2022 - 06/2007
21Hypertrophy
03/2022 - 09/2012
21Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 08/2010
21Cardiomegaly (Heart Hypertrophy)
01/2022 - 08/2013
19Pancreatitis
10/2020 - 02/2009
17Pain (Aches)
11/2021 - 07/2008
16Myocardial Infarction
01/2022 - 03/2005
15Adenocarcinoma of Lung
10/2022 - 01/2017
15Hemorrhage
05/2022 - 07/2013
15Necrosis
05/2022 - 02/2012
15Brain Ischemia (Cerebral Ischemia)
02/2022 - 06/2009
15Atherosclerosis
01/2022 - 04/2010
15Virus Diseases (Viral Diseases)
01/2022 - 01/2014
14Non-alcoholic Fatty Liver Disease
01/2022 - 01/2015
14Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2007
14Reperfusion Injury
01/2022 - 01/2012
13Triple Negative Breast Neoplasms
03/2022 - 03/2014
13Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 08/2015
13Adenocarcinoma
01/2022 - 05/2013
13Leukemia
01/2022 - 12/2007
13Diabetic Cardiomyopathies
01/2022 - 05/2010
13Atrial Fibrillation
12/2021 - 07/2012
13Colonic Neoplasms (Colon Cancer)
01/2021 - 09/2012

Drug/Important Bio-Agent (IBA)

182Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2002
114Biomarkers (Surrogate Marker)IBA
11/2022 - 05/2011
95Pharmaceutical PreparationsIBA
12/2022 - 07/2006
67MicroRNAs (MicroRNA)IBA
06/2022 - 01/2012
52CytokinesIBA
06/2022 - 03/2007
46Long Noncoding RNAIBA
06/2022 - 01/2015
45Biological ProductsIBA
07/2022 - 02/2011
44Messenger RNA (mRNA)IBA
06/2022 - 03/2005
41LipidsIBA
08/2022 - 02/2010
41Glucose (Dextrose)FDA LinkGeneric
06/2022 - 04/2011
34RNA (Ribonucleic Acid)IBA
10/2022 - 01/2013
33DNA (Deoxyribonucleic Acid)IBA
07/2022 - 05/2009
30EnzymesIBA
05/2022 - 06/2009
28Insulin (Novolin)FDA Link
01/2022 - 01/2006
27Therapeutic UsesIBA
12/2022 - 05/2002
27Interleukin-6 (Interleukin 6)IBA
04/2022 - 04/2009
27Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2002
26VaccinesIBA
11/2022 - 05/2009
24Circular RNAIBA
06/2022 - 10/2017
23AntigensIBA
04/2022 - 04/2005
23Cisplatin (Platino)FDA LinkGeneric
04/2022 - 07/2014
22Small Interfering RNA (siRNA)IBA
12/2021 - 10/2009
20AntioxidantsIBA
07/2022 - 05/2010
19Cytochrome P-450 CYP2J2 (CYP2J2)IBA
12/2021 - 07/2007
18Oxygen (Dioxygen)IBA
04/2022 - 12/2012
18Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 11/2011
17AcidsIBA
09/2022 - 02/2010
17AntibodiesIBA
05/2022 - 11/2011
17LigandsIBA
03/2022 - 01/2006
17Transcription Factors (Transcription Factor)IBA
10/2021 - 01/2011
16CollagenIBA
01/2022 - 09/2012
16Peptides (Polypeptides)IBA
01/2022 - 11/2004
15Immune Checkpoint InhibitorsIBA
05/2022 - 12/2018
15SeleniumIBA
04/2022 - 08/2012
14Hormones (Hormone)IBA
10/2022 - 05/2002
14salicylhydroxamic acid (SHAM)IBA
04/2022 - 03/2005
14Phosphotransferases (Kinase)IBA
01/2022 - 06/2009
14Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 08/2010
14ChemokinesIBA
10/2021 - 01/2016
13PlatinumIBA
11/2022 - 07/2016
13Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 03/2007
13Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 06/2010
13CholesterolIBA
03/2022 - 02/2010
13Triglycerides (Triacylglycerol)IBA
01/2022 - 02/2017

Therapy/Procedure

162Therapeutics
07/2022 - 06/2003
54Drug Therapy (Chemotherapy)
07/2022 - 01/2012
37Immunotherapy
05/2022 - 10/2009
24Radiotherapy
11/2022 - 01/2013
14Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 04/2011